Tessa M. Havinga-Rademaker - Publications

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: February 16, 2026

Quality of Life After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting.

Journal: Journal of the American Heart Association

Published: November 20, 2023

Validation of a simplified intravascular ultrasound core lab analysis method in stented coronary arteries.

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: April 01, 2022

Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: December 18, 2019

Reply: Periprocedural PCI Myocardial Biomarker Elevation and Mortality.

Journal: JACC. Cardiovascular interventions

Published: November 29, 2019

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.

Journal: JAMA cardiology

Published: September 27, 2019

Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: September 08, 2019

Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS.

Journal: The Canadian journal of cardiology

Published: August 21, 2019

Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: July 20, 2019

Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.

Journal: JACC. Cardiovascular interventions

Published: March 26, 2019

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: March 20, 2019

Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials.

Journal: JACC. Cardiovascular interventions

Published: October 05, 2016